zepbound mounjaro tirzepatide FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Most of Lilly's Mounjaro and
Description
tirzepatide to be more effective than s.c

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

Quickstart Highlights CagriSema is an investigational once-weekly, fixed-dose combination of two metabolic peptides in a single subcutaneous injection cagrilintide , a long-acting analog of the pancreatic hormone amylin, and semaglutide , a GLP-1 receptor agonist

The dual-receptor mechanism is believed to allow for greater weight reduction than GLP-1 receptor activation alone

One patient saw salivary flow drop from 30 mL (normal) to just 8 mL at three minutes on the modified Schirmer test
If you become pregnant while taking tirzepatide, talk to a healthcare provider right away to safely adjust your treatment plan